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Microarray Identification of FMRP-Associated
Brain mRNAs and Altered mRNA
Translational Profiles in Fragile X Syndrome
genes FXR1 and FXR2, encode a small family of RNA
binding proteins that share over 60% amino acid identity
(Ashley et al., 1993; Siomi et al., 1993, 1994; Zhang et
al., 1995). As an RNA binding protein, FMRP has been
shown to bind to RNA homopolymers as well as a subset
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and Stephen T. Warren1,2,6 of brain transcripts in vitro (Ashley et al., 1993; Brown
et al., 1998).1Howard Hughes Medical Institute
Department of Human Genetics FMRP is largely cytoplasmic, incorporated into large
messenger-ribonucleoprotein (mRNP) particles (Eber-Department of Pediatrics
2 Department of Biochemistry hart et al., 1996; Feng et al., 1997a, 1997b; Khandjian
et al., 1996; Tamanini et al., 1996). The FMRP-mRNP3 Department of Pharmacology
Emory University School of Medicine complex is composed of several proteins including other
RNA binding proteins such as FXR1P and FXR2P (Bar-Atlanta, Georgia 30322
4 Laboratory of Molecular Neuro-Oncology doni et al., 1999; Ceman et al., 1999, 2000; Schenck
et al., 2001). Purified FMRP displays an intrinsic RNAThe Rockefeller University
New York, New York 10021 binding capacity (Brown et al., 1998), and in the cyto-
plasm, FMRP-mRNP is associated with translating poly-5 Department of Microbiology
Duke University Medical Center ribosomes (Eberhart et al., 1996; Feng et al., 1997a;
Khandjian et al., 1996; Tamanini et al., 1996). A missenseDurham, North Carolina 27710
mutation in the second KH domain of FMRP (I304N),
which results in a severe fragile X phenotype, prevents
this polyribosome association, suggesting that theSummary
FMRP association with polyribosomes is functionally
important (De Boulle et al., 1993; Feng et al., 1997a).Fragile X syndrome results from the absence of the
RNA binding FMR protein. Here, mRNA was coimmu- A hypothesis has been posited that when FMRP is
absent, the mRNAs normally associated with FMRP-noprecipitated with the FMRP ribonucleoprotein com-
plex and used to interrogate microarrays. We identified mRNP complexes may be translationally misregulated,
which, in the brain, leads to cognitive deficits (Jin and432 associated mRNAs from mouse brain. Quantitative
RT-PCR confirmed some to be 60-fold enriched in Warren, 2000). To test this hypothesis, we have used
microarrays to identify mRNAs that are selectively asso-the immunoprecipitant. In parallel studies, mRNAs
from polyribosomes of fragile X cells were used to ciated with FMRP-mRNP complexes in the murine brain.
In a parallel approach, we also identified mRNAs thatprobe microarrays. Despite equivalent cytoplasmic
abundance, 251 mRNAs had an abnormal polyribo- exhibit abnormal polyribosome profiles in cells derived
from fragile X syndrome patients, suggesting that thesome profile in the absence of FMRP. Although this
represents 2% of the total messages, 50% of the absence of FMRP alters translation. Comparing these
two sets of mRNAs identifies a subset of messagescoimmunoprecipitated mRNAs with expressed human
orthologs were found in this group. Nearly 70% of that associate with FMRP in vivo and display abnormal
polyribosome profiles in the absence of FMRP. More-those transcripts found in both studies contain a G
quartet structure, demonstrated as an in vitro FMRP over, many of these mRNAs contain a G quartet struc-
ture, which has been shown to be the structural targettarget. We conclude that translational dysregulation
of mRNAs normally associated with FMRP may be the of FMRP (Darnell et al., this issue of Cell).
proximal cause of fragile X syndrome, and we identify
candidate genes relevant to this phenotype. Results
Introduction Strategy to Isolate and Identify mRNAs
Associated with FMRP-Containing
Fragile X syndrome is a common cause of mental retar- mRNP Particles
dation that results from a deficiency of the fragile X To identify mRNAs associated with FMRP in vivo, a
mental retardation protein, FMRP (Jin and Warren, strategy was devised to specifically immunoprecipitate
2000). FMRP is encoded by FMR1, an X-linked gene FMRP-containing mRNP particles and to identify the
that harbors a (CGG)n trinucleotide repeat in its 5 un- copurified mRNAs by probing microarrays. A similar
translated region. In most patients, this repeat under- strategy was used previously to identify mRNA targets
goes expansion that leads to transcriptional silencing of the ELAV/Hu neuronal protein, HuB (Tenenbaum et
of the FMR1 gene (Verkerk et al., 1991; Oberle et al., al., 2000). For murine FMRP, a monoclonal antibody
1991; Sutcliffe et al., 1992). (mAb 7G1-1) was developed by immunizing the Fmr1
FMR1 and its autosomal paralogs, the fragile X-related knockout (KO) mice with mouse FMRP (Brown et al.,
1998). The epitope recognized by mAb 7G1-1 was
mapped to a region of nonhomology with the Fxr1 and6 Correspondence: swarren@emory.edu
7 These authors contributed equally to this work. Fxr2 proteins (Figure 1A). Immunoprecipitations from
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whole brain lysates of wild-type (wt) and KO sibling
mice (congenic on the C57Bl/6J strain) revealed that the
antibody efficiently immunoprecipitates at least three of
the predominant FMRP isoforms (Figure 1B, a). Although
the antibody does not immunoprecipitate the Fxr pro-
teins from KO brains (Figure 1C, lanes KO), both FXR1P
and FXR2P were found associated with FMRP in wt
mouse brain (Figure 1C, lanes WT, b and c), demonstra-
ting the immunoprecipitation of the mRNP complex. Nu-
cleic acid extraction of the immunoprecipitant and oligo
dT-primed reverse-transcription showed the presence
of poly(A) RNA. Very little background RNA was found
in the control immunoprecipitations from the KO brain
lysates (Figure 1D).
Microarray Analysis of the Resident mRNAs
in the FMRP-mRNP Complex
En masse identification of the mRNAs coimmunopreci-
pitated with the FMRP mRNP complex was achieved
using the Affymetrix Murine Genome U74 (MG-U74) and
Murine 19K (Mu19K) oligonucleotide microarrays. These
arrays allowed the interrogation of 25,181 RNAs from
the UniGene database and 19,021 messages from the
TIGR database. For independent array screens, fresh
lysates from pooled wt and from pooled KO brains (2
each) were prepared, and 20% of the total volume of
each lysate was used to isolate total RNA as input RNA.
The remainder of the brain lysates was subjected to
7G1-1 mAb immunoprecipitation (IP) followed by RNA
extraction to isolate the IP RNA. wt-IP and KO-IP RNA
samples were used to generate cRNA that was hybrid-
ized, in parallel with cRNA generated from input RNA,
onto identical MG-U74 arrays. As shown in Figure 2A,
the microarrays probed with input RNA exhibited bright
fluorescence, consistent with the complex gene expres-
sion pattern of the murine brain. Less than 0.05% of the
RNAs were substantially changed when comparing wt
versus KO whole brain lysates (unpublished data), indi-Figure 1. Immunoprecipitation of the FMRP-mRNP Complex
cating that FMRP deficiency does not result in wide-(A) Left: Competitive Western blot analyses were performed
spread mRNA changes at steady state. Consistent withwith purified FLAG-FMRP and probed with 7G1-1 antibody mixed
earlier studies that suggested FMRP associates withwith the indicated peptide competitors at 1000  molar excess.
only a subset of mRNAs (Ashley et al., 1993), the wt-IPThe labels mean the following: none, no peptide; 7G1-1 #1,
354KHLDTKENTHFSQPN368; and 7G1-1 #2, 367PNSTKVQRVLVSSIV382. microarrays showed substantial intensity loss for most
Right: Peptide 7G1-1 #1 blocks immunoprecipitation of FMRP. Ly- of the genes found to be expressed in the input lysate.
sates prepared from the FLAG-FMRP-expressing L-M cells (Ceman The KO-IP microarrays exhibited further intensity loss
et al., 1999) were immunoprecipitated with 7G1-1 that was untreated
when compared to the WT-IP. Although detectable sig-(none), preincubated with the irrelevant FLAG M2 peptide (M2), or
nals were evident on the KO-IP arrays, these were pre-preincubated with the peptide 7G1-1 #1 (7G1-1 #1). Antibody matrix
sumably due to background interactions with the anti-alone is shown in the lane marked Ig. Precipitates were probed
with the 1C3 anti-FMRP antibody. FMRP is indicated by the arrow; body matrix, independent of FMRP.
antibody chains are indicated by the bracket. Bottom: Partial protein Of the 25,181 total genes available on the MG-U74
alignment of human (h) and murine (m) Fmr and Fxr proteins. mAb microarray, 11,067 genes (44%) were present in the
7G1-1 recognize the boxed amino acids 354–368 of mFMRP, in a total wt brain lysate. The analysis of the coimmunopreci-
region with no homology to the Fxr paralogs.
pitated mRNA was carried out in two parts; first, the wt-(B) Whole brain lysates were prepared from wt or Fmr1 KO mice,
IP mRNA profile was analyzed using the KO-IP mRNAimmunoprecipitated with the mAb 7G1-1, and probed with the 1C3
profile as the baseline, and second, wt-IP mRNA profileanti-FMRP antibody. The labels mean the following: lysate, input;
flow thru, unbound; and IP, immunoprecipitated material. (a) indi- was compared against the total wt input RNA profile.
cates FMRP isoforms, and (d) indicates antibody chains. The former analysis presumably identifies FMRP-inde-
(C) Paralogs, FXR2P and FXR1P coprecipitate with FMRP. The left pendent mRNAs associated with the antibody matrix,
panel shows probing with (a) anti-FMRP antibody (1C3), and (b) anti- while the latter analysis identifies those mRNAs scored
FXR2P antibody (A42). A separate aliquot was probed with anti-
as present in the wt-IP relative to the wt input, discardingFxr-1 antiserum (right panel, c).
those mRNAs whose high abundance in the input lysate(D) FMRP associates with poly(A) RNA in mouse brain. Immunopre-
may be responsible for their presence in the IP sample.cipitations were performed from wt and KO brain lysates, RNA was
extracted, and first strand cDNA was generated and visualized by While discarding genes in either of these approaches
autoradiography. may remove bona fide FMRP-associated messages, it
FMRP mRNA ligands
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Figure 2. Analysis of the RNAs Coimmuno-
precipitated with the FMRP-mRNP
(A) The MG-U74 gene chips were hybridized
with cRNA generated from total RNA from wt
brain input lysate (input, left panel), from RNA
coimmunoprecipitated with FMRP from wt
mouse brain (wt-IP, center panel), or from
RNA immunoprecipitated from Fmr-1 KO
mouse brain (KO-IP, right panel).
(B) Venn diagram of the RNAs associated with
the FMRP-mRNP. The square depicts the
genes available on the MG-U74 chips. The
white ellipse represents the genes detected
in the wt brain lysate input. The red circle
indicates the genes enriched in the wt-IP ver-
sus KO-IP. The green circle shows the genes
enriched in the wt-IP versus the input. The
yellow intersection indicates those genes en-
riched in the wt-IP in both analyses.
results in a relatively stringent selection and should mini- change factor. The transcript for SAPAP4, encoding the
PSD95-associated protein 4, had the highest wt-IP en-mize false positives. As displayed in the Venn diagram
(Figure 2B, red circle), 2,902 mRNAs (26% of expressed richment over wt input lysate, which was approximately
34-fold. The highest average difference changes of themessages) were at least 4-fold enriched in the wt-IP
mRNAs when compared to the KO-IP mRNAs. However, wt-IP relative to the message prevalence in the lysate
was approximately 18,000 and 14,000 for the transcriptmany of these enriched mRNAs are also found at high
abundance in the input lysate such that, of the 11,067 similar to Peroxidasin and the Septin 3 GTPase, respec-
tively. All transcripts ranked in the top 20 had averageexpressed genes in the total input brain lysate, only 527
mRNAs (5% of expressed messages) showed a 4-fold difference changes (versus input) in excess of 1,000.
An independent immunoprecipitation experiment wasor greater enrichment over the input lysate by immuno-
precipitation (Figure 2B, green circle). Combining these performed and analyzed with a different version of the
Affymetrix murine gene chips, the Mu19K expressiontwo results showed that 15% of the 2,902 genes identi-
fied in the first analysis and 82% of the 527 genes identi- array. By using the same criteria as in the MG-U74 exper-
iment, genes showing a 4-fold or greater enrichmentfied in the second analysis were identical and met both
criteria for enrichment in the wt-IP (Figure 2B, yellow during the immunoprecipitation were identified (full data
sets available as supplemental data). When the two in-region). The intersection conservatively represents 432
genes, or 3.9% of the 11,067 expressed RNAs. This dependent experiments were compared, 36 of the top
80 RNAs described in Table 1 were not available onnumber is remarkably consistent with an earlier and
much more crude estimate, suggesting that 4% of the Mu19K chips, and therefore were not tested by the
Mu19K data (Table 1, N/A). However, the Mu19K arrayhuman fetal brain messages associated with FMRP in
vitro (Ashley et al., 1993). data confirmed the FMRP-mRNP enrichment for 28 of
the 44 genes tested (64%) (Table 1). It should be noted,The top 80 mRNAs enriched in the FMRP-mRNP are
shown in Table 1 (full data sets available as supplemen- however, that a number of genes were represented on
both array types but with different sequences in thetal data at http://www.cell.com/cgi/content/full/107/4/
477/DC1). The genes were sorted in descending order oligonucleotides, potentially confounding reproduction
of the MG-U74 data.by the “fold change” in the wt-IP versus KO-IP (baseline)
comparison, and then sorted again in descending order
by the fold change in the wt-IP versus input (baseline) Confirmation of the Association between FMRP-
mRNP and the mRNAs Identified by Microarrayscomparison. The final rank of each probe set reflects
the sum of these 2-fold change values: (wt-IP versus To independently demonstrate that the mRNAs identi-
fied in Table 1 are associated with the FMRP-mRNP,KO-IP)  (wt-IP versus input). The largest message en-
richment in the wt-IP when compared with the KO-IP fresh immunoprecipitations were performed in the pres-
ence of an excess of nonspecific RNA competitors, ei-was 77-fold for a Sec7-related transcript KIAA0763,
identified by homology as the guanine nucleotide ex- ther yeast tRNA or heparin. Neither tRNA nor heparin
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Figure 3. FMRP-mRNP Associated RNAs Are
Specific to the FMRP-Containing Complex
(A) Immunoprecipitations from mouse brain
lysates were performed with anti-U1-70Kp
antibody (left panel) or anti-FMRP 7G1-1 anti-
body (right panel). Western blots of immuno-
precipitates were probed with antibody
against the U1-70K protein (left panel) or the
1C3 antibody against the FMRP protein (right
panel). “Lysate” indicates input brain lysates;
“IP” indicates immunoprecipitated proteins.
The bracket at right indicates the antibody
chains.
(B) Examples of RT-PCR analyses of the anti-
U1-70K and anti-FMRP immunoprecipita-
tions. RNA was purified from the immunopre-
cipitates above and reverse transcribed prior
to the PCR. “Tot.RNA” indicates wt mouse
brain total RNA, “U1” indicates the anti-U1-
70K immunoprecipitations, and “F” indicates
the analysis of the anti-FMRP immunoprecip-
itations. DNA molecular weight standard is
shown at left. PCR primers used are (left to
right) U1snRNA, GAP-associated protein 190,
murine TPRD, Casein Kinase CK1g2, and
mGluR4, an unbound control.
abrogated the specific RNA association with the FMRP- found to be highly enriched in the IP by quantitative RT-
PCR. Indeed, the Sec7-related gene, predicted by themRNP for a random group of messages from Table 1
(data not shown). We next asked if an RNA ligand that microarray analysis to be highly enriched in the wt-IP,
showed a greater than 60-fold enrichment in the wt-IPcopurifies with another RNP would be present in the
FMRP-mRNP. The U1-70K small nuclear RNP (snRNP) is over the wt input by LightCycler analysis. The above
experiments confirm the microarray data and demon-a splicing complex that specifically binds the U1 snRNA
(Query et al., 1989). This complex was immunoprecipi- strate that a subset of brain mRNAs is reproducibly
associated with the FMRP-mRNP complex from thetated from fresh wt and KO lysates with an anti-U1-70K
mAb, and in parallel the FMRP-mRNP was immunopre- mouse brain.
cipitated from the same lysates (Figure 3A). The anti-U1-
70K antibody efficiently precipitated the U1-70K protein Altered Polyribosomal mRNA Profile
in the Absence of FMRPfrom both wt and KO brain lysates, whereas the anti-
FMRP 7G1-1 antibody precipitated FMRP, as expected, While the above experiments point to potential RNA
ligands of the FMRP-mRNP complex, they do not ad-only from the wt brain lysate. The RNA recovered from
each precipitation was analyzed by RT-PCR (Figure 3B). dress any functional attributes of this association. In an
independent series of experiments, microarray analysisFor each gene of interest, the primer pairs were also
tested in a RT-PCR reaction with 0.1 g of total brain was again utilized, but now was used to discern any
shifts in individual mRNAs, in the presence or absenceRNA (Figure 3B, Tot.RNA). The U1snRNA, previously
determined to be the U1-70K ligand, was enriched in of FMRP, on a sucrose gradient that fractionates mes-
sages by their relative association to ribosomes. Previ-the U1-70K precipitates from both wt and KO mouse
brain. However, this same RNA was not found in sub- ous studies have shown most FMRP to be in the polyri-
bosome fractions of cell lysates (Eberhart et al., 1996;stantial amounts in the FMRP precipitate (Figure 3B).
In contrast, the eight tested FMRP-associated mRNAs Feng et al., 1997a; Khandjian et al., 1996; Tamanini et
al., 1996). In fragile X cells, without FMRP, the FXR pro-were only found in the FMRP precipitates from wt mouse
brain and not in the U1-70K precipitates nor in the control teins do not substantially change their associations with
polyribosome (Feng et al., 1997a). Thus, it appears thatanti-FMRP immunoprecipitation from KO brain (Figure 3B
and data not shown). In a set of random mRNAs that a similar mRNP may form with just the FXR proteins,
although it may be hypothesized that the absence ofwere not enriched in the FMRP-mRNP microarray studies,
including the neuronal mGluR4, Dynamin, and Homer FMRP in this complex could alter the translational profile
of a subset of mRNAs. To test this hypothesis, we uti-messages, none were detected in either the U1-70K or
FMRP complexes (Figure 3B and data not shown). lized microarrays to compare the mRNA profiles of high-
molecular-weight polyribosomes between normal hu-To further confirm the microarray data, we performed
quantitative LightCycler RT-PCR analysis by using man cells and cells derived from fragile X syndrome
patients. If changes in the translational profile of mes-RNAs from wt-IP and wt input. As shown in Table 2, of
three tested mRNAs that were not found by microarray sages are observed in the absence of FMRP, these
mRNAs should (at least partially) correlate to the immu-analysis to be enriched in the wt-IP, all showed little
enrichment upon LightCycler analysis. In contrast, three noprecipitation data if it is functionally important.
To reduce any inherent individual variation that is un-genes that were found in the microarray analysis to be
enriched in the wt-IP, relative to wt input, were also related to FMRP, we performed sucrose gradient frac-
Cell
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Table 2. Verification of Microarray Data using LightCycler Real-Time PCR
Association with FMRP-mRNP Scaled Fold Enrichment in
Mouse UniGene Determined by Microarray wt-IP over wt-INPUT by
Genes Cluster Analysis LightCycler PCR
Similar to microsomal glutathionse S-transferase 3 Mm. 29823 No 1.87
Glutamate receptor, ionotropic, AMPA1 Mm. 4920 No 	1.83
Synaptotagmin 1 Mm. 5101 No 1.02
KIAA0317 protein Mm. 24446 Yes 31.3
TP63 Mm. 54143 Yes 36.8
Sec7-rel. GEF similar to KIAA0763 Mm. 89798 Yes 60.5
tionation from pooled (five cell lines each) as well as types (i.e., the proportion of a message on high-molecu-
lar-weight polyribosomes) (Figure 4B). These genesfrom individual human lymphoblastoid cell lines, derived
from either normal males or fragile X full mutation males. were clustered into two groups based on whether they
were increased or decreased in the polyribosomes ofConsistent with previous observation (Feng et al.,
1997a), in pooled normal cells, FMRP associates with fragile X cells, as indicated by the shading in Figure 4B.
Of the 251 genes, 136 were increased and 115 de-polyribosomes (Figure 4A). Neither FMR1 message nor
FMRP can be detected in any of the fragile X cell lines creased in the polyribosomes of fragile X cells (full data
sets available as supplemental data).(Figure 4A and data not shown). RNA was purified from
total cytoplasmic extract (total mRNA), as well as from To verify these data, we performed quantitative
LightCycler RT-PCR. A control gene, X-linked hypoxan-the high-molecular-weight polyribosome fractions (frac-
tions 9–11, Figure 4A). cRNA was prepared for hybridiza- thine phosphoribosyl transferase (HPRT), which did not
show any change in either polyribosomal fractions ortion onto microarrays containing more than 35,000 hu-
man genes and/or ESTs (Affymetrix Hu35K). mRNA total mRNA on microarray analysis, was also unchanged
in the RT-PCR experiments (data not shown). Consistentprofiles of polyribosomal fractions from both individual
and pooled fragile X cells were compared with polyribo- with microarray data, quantitative RT-PCR showed that
the transcript levels of NAP-22 and MKPX decreased insomal fraction from either individual normal cells or
pooled normal cells (baselines). In addition, expression the polyribosomal fractions of fragile X cells while
GRP58 increased in these fractions. There was no signif-profiles of total mRNA from pooled cells were compared
to each other as well. icant change in total mRNA from any of the three genes
(data available as supplemental data). To further confirmOverall, of 35,000 genes analyzed, 11,000 were
present, indicating that about one-third of the genes the microarray data, the distribution of NAP-22 and
MKPX messages in freshly prepared sucrose gradientrepresented on the microarray are expressed in human
lymphoblastoid cells. As might be expected, greater fractions were probed by Northern blot. As shown in
Figure 5, both NAP-22 and MKPX were reduced in polyri-variation in gene expression was observed when the
samples were derived from individual cell lines, rather bosomal fractions of fragile X cells, although total cyto-
plasmic RNA showed no differences between normalthan from the pooled cells (data not shown). In fragile
X cells, the FMR1 locus is transcriptionally repressed and fragile X cells. Moreover, these data extend the
microarray and LightCycler data to include gradient(Sutcliffe et al., 1992) and therefore serves as an ideal
internal control. On the microarray, the FMR1 mRNA fractions 5–8, revealing an even more striking transla-
tional profile shift in fragile X cells, particularly for MKPX.was clearly present in total mRNA from normal cells but
was absent in fragile X cells. In polyribosomal fractions, Glyceraldehyde phosphate dehydrogenase (GAPDH),
as a control, did not show any difference between nor-the FMR1 mRNA was present in normal cells, although
at a low level, but again was completely absent in fragile mal and fragile X cells throughout the gradient or in total
RNA (Figure 5). These results confirmed the selectiveX cells (Figure 4C). Thus, this approach correctly identi-
fied the one known difference in mRNA expression be- translational profile shift of a subset of mRNA in the
absence of FMRP.tween the normal and fragile X cells.
Overall, 144 genes from pooled fragile X cells were
changed compared to pooled normal cells in the total Correlation of Immunoprecipitated mRNAs
with Those Showing a Translational ProfilemRNA, while 282 genes showed consistent changes in
the fragile X polyribosome fractions (pooled or individual Shift in Fragile X Syndrome Cells
To compare the genes associated with FMRP-mRNPfragile X cells) compared to the normal polyribosome
fraction (pooled or individual normal cells). Of these 426 in the mouse brain with the human genes exhibiting
abnormal polyribosomal shift in the absence of FMRP,genes, 31 were found in both data sets (Figure 4B).
Because the alteration of a message in the total mRNA we searched HomoloGene database using the UniGene
clusters that represented the mouse genes of interest,may influence the amount of that message in the polyri-
bosome fractions, these 31 mRNAs were eliminated and we identified UniGene clusters of the human or-
thologs of these genes. Conversely, using the humanfrom further analysis. The remaining 113 genes that
showed differences in total mRNA were not considered UniGene clusters and probe set information provided
by the manufacturer (EASI DATABASE v2.41, Affyme-further here. Hence, we were left with 251 genes that
show equivalent levels of expression in the total mRNA trix), the oligonucleotides that represent the murine or-
thologs of the human genes were also identified. Of theof pooled fragile X and normal cells but displayed con-
sistent translational profile shift between the two cell top 80 genes identified in mouse microarray analysis
FMRP mRNA ligands
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Figure 5. Northern Blot Analysis of Genes Changed in the Polyribo-
somal Profiles of Fragile X Cells
The top panel shows the absorption profile of sucrose gradient with
the sedimentation indicated. Western blot shows the distribution
of FMRP in correlation to fractions. Northern blot shows mRNA
distribution from fractions 5 to 11 in the sucrose gradient, between
normal and fragile X cells. An equal volume of RNA from each frac-
tion was hybridized with different probes for selected genes, includ-
ing GAPDH (control), MKPX, and NAP-22.
tated with FMRP but did not exhibit abnormal polyribo-
somal shift, may represent mRNAs associated with the
Fxr proteins, potentially revealing the speculated partialFigure 4. Comparative Analysis of mRNA Profiles from Polyribo-
compensatory functions of the Fxr proteins. The mRNAssomal Fractions and Total mRNA between Normal and Fragile X
Cells that differentially associated with the polyribosomes of
fragile X cells and were also found in the FMRP-mRNP(A) Sucrose gradient fractionation of pooled normal and fragile X
cells. The top panel shows the absorption profile of the sucrose particle are shown in Table 3. Approximately half of
gradient with the sedimentation indicated. The bottom two panels these were increased (6/14) and half were decreased
show the distribution of FMRP by Western analysis. Fraction num- (8/14) in the high-molecular-weight polyribosomes of
bers are indicated below the corresponding lanes, and fractions
fragile X cells. Although FMRP has been shown to sup-9–11, used for microarray analysis, are underlined.
press translation of bound messages in vitro (Li et al.,(B) Venn diagram of the number of genes altered in polyribosomal
2001; Laggerbauer et al., 2001), perhaps accounting forfractions and total lysate.
(C) Dendrogram of genes with significant changes in the polyribo- the 6 messages showing increased loading on polyribo-
some profile of patient cells. Samples used for each comparison somes in the absence of FMRP, the exact effect of FMRP
are indicated on the top, and data from normal cells are used as on translation in vivo would appear to be more complex.
baseline for all comparison. Genes that were present at higher levels
In the accompanying paper by Darnell et al. (2001 [thisin the patient cells are shown in progressively brighter shades of
issue of Cell]), a G quartet structure was identified inred, and genes that were expressed at lower levels are shown in
vitro as the RNA target of the RGG box domain of FMRP.progressively brighter shades of green. Genes shown in black were
not changed. The FMR1 gene (highlighted in yellow) is decreased Of the 12 genes in Table 3 where sufficient sequence
in both polyribosomal fractions and total mRNA of patient cells. The information existed for the analysis, eight (67%) genes
identities of those genes are available from the electronic version showed the presence of a G quartet structure. Consider-
of this manuscript at http://www.cell.com/cgi/content/full/107/4/
ing that only 4% of a random collection of cDNAs are477/DC1.
predicted as possible FMRP targets, the observation
that 67% of the transcripts independently determined
to both immunoprecipitate with FMRP and display a(Table 1), 48 genes are represented on the Human 35K
translational profile shift in the absence of FMRP cer-set oligonucleotide microarray. Among these 48 genes,
tainly points to the G quartet structure as being physio-28 are expressed in the human lymphoblastoid cells,
logically relevant in fragile X syndrome.and 14 (50%) were differentially associated with polyri-
bosomes in the normal versus fragile X cells. This ap-
pears rather significant, because the entire polyribo- Discussion
somal mRNA profile of normal versus fragile X cells,
comparing some 11,000 messages, showed only 2% of Soon after the discovery of the FMR1 gene, FMRP was
recognized as an RNA binding protein, although the inthe messages as changed in the polyribosome fractions.
The other 14 genes, whose messages coimmunoprecipi- vivo target RNAs have remained elusive (Ashley et al.,
Cell
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Table 3. Changed mRNAs in the Fra(X) Polyribosome Fraction that also Co-immunoprecipitate with Mouse Brain Fmrp mRNP
Presence of G Human UniGene Mouse UniGene Change in the Polyribosome
Gene Name Quartet Structure Cluster Cluster Fraction of Fra(X) Cells
KIAA 0964, PSD-95 assoc. SAPAP4 absent Hs. 177425 Mm. 22094 Decrease
UNC13 (C. elegans)-like protein 3 UTR Hs. 155001 Mm. 7872 Decrease
(Munc 13)
KIAA 1091, Rab6 interacting protein 1 coding region Hs. 26797 Mm. 21904 Decrease
Similar to adenylate cyclase unknown Hs. 9572 Mm. 41626 Decrease
Similar to MKP-dusPTPase absent Hs. 29106 Mm. 46262 Decrease
TP63 3 UTR Hs. 137569 Mm. 54143 Decrease
Casein kinase 1, gamma 2 absent Hs. 181390 Mm. 29873 Decrease
NAP-22 coding region Hs. 79516 Mm. 29586 Decrease
MAP1B 5 UTR Hs. 103042 Mm. 36501 Increase
Similar to I38022 hypothetical protein unknown Hs. 10299 Mm. 24385 Increase
KIAA0929 protein, Msx2 interacting coding region Hs. 184245 Mm. 25025 Increase
nuclear target (MINT) homolog
KIAA0317 protein 3 UTR Hs. 20126 Mm. 24446 Increase
Arg/Abl-interacting protein (ArgBP2) absent Hs. 278626 Mm. 32247 Increase
Transmembrane protein 1, TMEM1 3 UTR Hs. 94479 Mm. 27539 Increase
(GT334)
1993; Siomi et al., 1993). Many studies have character- ing substantially greater relative abundance in the im-
munoprecipitated mRNP.ized the RNA binding behavior of FMRP in vitro or in
cell-free systems (Ashley et al., 1993; Brown et al., 1998; Quantitative RT-PCR using LightCycler technology
confirmed that a tested subset of transcripts predictedSiomi et al., 1993, 1994; Sung et al., 2000); however, the
work described here identifies the repertoire of RNAs to be enriched by the microarray data were indeed ap-
proximately 30- to 60-fold enriched in the wt-IP relativeassociated in vivo with the endogenous FMRP protein
complex and shows translational profile changes in the to the wt input lysate. This included the top ranking
transcript in Table 1, the Sec7-related guanine nucleo-absence of FMRP.
tide exchange factor, which was confirmed in indepen-
dent lysates to be approximately 61-fold enriched in theLarge-Scale Identification
FMRP-mRNP. It should be noted however, that givenof FMRP-mRNP-Associated mRNAs
the 3 bias and the relatively short interval of cDNAThe FMRP-immunoprecipitating mAb, 7G1-1, allows, for
sequence used in designing the oligonucleotide se-the first time, the purification of endogenous FMRP-
quences of microarrays, false negatives occur, perhapsmRNP complexes. The FMRP-mRNP complex was
due to alternative splicing or to consolidation of genefound to be associated with 3.9% of the expressed
family members. A case in point is the NAP-22 transcript.genes in mouse brain. The Fmr1 message was not
On the Mu19K microarray, NAP-22 was enriched in theamong these messages despite in vitro studies showing
wt-IP but subsequently failed to be scored highly on theFMRP association with its own mRNA (Ashley et al.,
MG-U74 microarray. After noting that NAP-22 displays1993; Brown et al., 1998). The Fmr1 message was de-
a translational profile shift in the absence of FMRP, thetected at a moderate level in the wt brain lysate, with
association of the NAP-22 transcript with the FMRP-an input (baseline) average difference value of 114 and
mRNP was reinvestigated using quantitative RT-PCRwas undetected, as expected, in KO input lysate. In
and was shown to be 63-fold enriched in the wt-IP rela-comparison, 32% of the expressed genes had signal
tive to the total brain lysate. Since the newer MG-U74intensities higher than the Fmr1 in the input lysate. There
microarray used EST-derived sequence to develop dif-was a moderate 4.2-fold increase in the Fmr1 transcript
ferent oligonucleotides than those used in the Mu19Kwhen the WT-IP RNA was compared to the KO-IP RNA
microarray, it is probable the two microarrays may be(average difference change of 225), but no enrichment
assaying different isoforms or family members for somewas found when comparing the wt-IP RNA to the wt
genes. While it is likely the number of such genes is notinput RNA. Although the Fmr1 transcript may be a legiti-
high, this discrepancy, along with our relatively highmate FMRP ligand, in light of the data presented here,
stringency of analysis, suggests that we are somewhatit is likely there are other messages with much more
underestimating the number of transcripts associatedavidity to this mRNP complex. Indeed, in contrast to
with the FMRP-mRNP.Fmr1, other mRNAs were detected at extremely low
levels in the wt brain lysate input yet were greatly en-
riched in the FMRP-mRNP. This group includes mes- Altered Polyribosomal-Association of mRNAs
in the Absence of FMRPsages predicting a KIAA0561-like protein, the Rab3
GDP/GTP exchange protein, and the Celera mRNA It has been hypothesized that FMRP may be incorpo-
rated into an mRNP-complex with its mRNA ligandshCT25324, which is predicted by TBLASTX to encode
an ubiquitin-ligase-like protein. In these cases, these and, in turn, associate with translating polyribosomes,
somehow modulating the translation of those mRNAmessages were called “absent” in the input lysate. And
yet, the average difference changes were 1114, 1270, ligands (Jin and Warren, 2000). Using microarrays, we
have now identified a subset of mRNAs that are alteredand 916, respectively, in the IP versus the input, indicat-
FMRP mRNA ligands
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in the high-molecular-weight polyribosome fraction of but were unchanged in their total RNA abundance in
fragile X cells, most of which (251 out of 282) did not cytoplasmic lysates (supplemental data available). These
change in abundance in the total mRNA. These changes observations strongly imply that the G quartet structure
may imply an alteration in translation regulation in the is biologically relevant to fragile X syndrome.
absence of FMRP. Considering that synaptic abnormali-
ties have been reported in both fragile X syndrome pa-
tients and the Fmr1 knockout mouse, it is of substantial FMRP mRNA Ligands and the Pathogenesis
interest that several of the mRNAs that exhibited an of Fragile X Syndrome
abnormal polyribosome shift in fragile X syndrome cells The above results suggest that roughly 4% of brain
are involved in neuronal plasticity and development/ transcripts are possible targets for FMRP. Given the
maturation of synapses, including NAP-22, neuritin, syn- relatively subtle features of fragile X syndrome, it might
aptosomal-associated protein 23, MAP1B, UNC13-like be considered surprising that the translational alteration
protein, and SAPAP4 (Aravamudan et al., 1999; Augustin of such a substantial number of messages does not lead
et al., 2001; Caroni, 1997; Edelmann et al., 1996; Frey to a more severe phenotype. However, it may be only
et al., 2000; Hinton et al., 1991; Naeve et al., 1997; Nim- a smaller subset of mRNAs, perhaps those with the
chinsky et al., 2001; Takeuchi et al., 1997). greatest binding affinity to FMRP, are most influenced
by the absence of FMRP. In addition, the translational
FMRP-Specific mRNA Ligands profile shifts seen in the absence of FMRP does not
and a G Quartet Structure completely remove the affected transcripts from the
Comparing the genes identified in the complementary polyribosomes. Accordingly, it would be expected that
approaches, we find that only 2% of the expressed some of the encoded protein of the affected transcripts
genes surveyed showed a translational profile shift in would still be produced. Thus, the consequence of the
the absence of FMRP, yet 50% of the mRNAs that are absence of FMRP may indeed be a rather subtle cellular
both found in the FMRP-mRNP complex and expressed effect, perhaps most damaging in sensitive regions of
in human cells belong to this group. Because we immu- localized protein synthesis such as in neuronal processes.
noprecipitated from mouse brain (since the 7G1-1 mAb The identified transcripts reported above encode a
does not recognize human FMRP) and did the transla- myriad of proteins involved in neuronal function. The
tional studies in human cells (since polyribosome pro- top-ranked probe set is the mouse ortholog of the hu-
files are problematic from brain tissue), there were some man transcript for the Sec7-related guanine nucleotide
limitations in the comparison of the data sets, due to exchange factor (Jackson and Casanova, 2000; Mayer
tissue-specific expression and species-specific mi- et al., 2001). Sec7 domain-containing proteins, Munc13
croarrays. However, the data strongly support the notion (a family of phorbol ester receptors), and ARF (an ADP-
that the FMRP-mRNP complex recognizes specific ribosylation factor) are all involved in Golgi vesicle matu-
mRNAs and modulates their translation on polyribosomes. ration and vesicle transport in neurons (Augustin et al.,
We have hypothesized that RNA binding proteins in 2001; Neeb et al., 1999). Similarly, many of the other
mRNP complexes interact with specific cis elements
messages found (Table 1) associated with the FMRP-
in a subset of mRNAs, allowing the transcripts to be
mRNP complex compose an interesting mix of novel
regulated at the posttranscriptional level (Keene, 2001;
messages and those whose encoded functions are in-
Tenenbaum et al., 2000). This hypothesis predicts that
triguing in light of fragile X syndrome. For example, mes-one or more structural elements may be in common
sages encoding proteins such as SAPAP4, DAP-1, andamong a set of mRNAs found in mRNP complexes. In-
the kainate receptor were enriched in the FMRP immu-deed, such a structural element, in the form of a G
noprecipitation, and these proteins are found closelyquartet, has been identified in FMRP RNA ligands by
associated with the postsynaptic density and are in-Darnell et al. (2001 [this issue]). It is remarkable that
volved in maintaining the PSD structure and neuronal67% of the transcripts that both immunoprecipitate with
cell signaling (El-Husseini et al., 2000; Paschen et al.,the FMRP-mRNP complex in the mouse brain and dis-
1994; Satoh et al., 1997; Takeuchi et al., 1997). Recentplay a translational profile shift in the patient cells are
studies showing abnormal maturation and arborizationpredicted to contain a G quartet structure. Indeed, Dar-
of hippocampal neurons from Fmr1 KO mice and fragilenell et al. (2001 [this issue]) has found that 11 messages
X patients are consistent with the altered translation ofin Table 3 bind to FMRP in vitro with affinities ranging
these and other postsynaptic proteins (Braun and Segal,from 194 nM to 599 nM. Moreover, the top-ranked Sec7-
2000; Hinton et al., 1991; Nimchinsky et al., 2001; Weilerrelated guanine nucleotide exchange factor (Table 1) is
et al., 1997). One of the next challenges generated frompredicted to have a strong G quartet structure, binds
these data is to determine which candidate mRNAs areFMRP in vitro with an affinity of 322 nM, and shows Li
most critical to fragile X pathophysiology. The data re-binding sensitivity, indicative of a G quartet element
ported here provide the necessary ingredients for further(Darnell et al., 2001 [this issue]). In addition, we have
inquiry into the molecular basis of this frequent form oftested messages predicted by Darnell et al. to be FMRP
cognitive deficiency. Moreover, given the phenotypicligands and have observed that two candidates exam-
overlap between fragile X syndrome and other neuro-ined (ID3 and V1a receptor) were both enriched in the
psychiatric disorders such as autism and attention defi-FMRP immunoprecipitates from mouse brain. Of four
cit/hyperactivity, the mRNAs identified here may be con-candidates in humans, two (semaphorin 3F and, again,
sidered a cache of candidate genes for these disordersthe V1a receptor) were decreased in the polyribosome
fractions of patient cells (5.5- and 2-fold, respectively) as well.
Cell
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Experimental Procedures profile analysis, cRNAs generated from polyribosomal fractions and
total mRNA were hybridized to Human 35K (Hu35K) arrays. All the
arrays were scaled to an average intensity of 500 and analyzedAntibodies
Monoclonal antibody 7G1-1 was generated by immunizing Fmr1 independently using Affymetrix Microarray Suite 4.0 software. The
dendrogram was generated using GENECLUSTER, as describedknockout mice (The Dutch-Belgian Fragile X Consortium, 1994) with
hexahistidine-tagged FMRP (Ceman et al., 2001). The FMRP-epitope (Eisen et al., 1998).
recognized by 7G1-1 was identified by screening an expression
library prepared from a partial exonuclease/DNase digestion of the cDNA Synthesis, RT-PCR, and LightCycler Real-Time PCR
Fmr1 cDNA cloned into Novatope vector (Novagen). Competitive The first strand cDNA was generated by reverse transcription with
Western blot and immuoprecipitation were done to confirm the epi- oligo dT primer or random hexamers. The 32P-labeled UTP first
tope. The extensive description of these protocols is published on- strand cDNA was analyzed via surface tension agarose gel electro-
line as supplemental data. The 1C3 anti-FMRP was provided by Dr. phoresis. In RT-PCR analysis, 1 l of the RT reaction was used in
J.-L. Mandel (Institute of Genetics, Illkirch, France), anti-FXR2P (A42) a 27 cycle PCR reaction for each target gene, and products were
was a gift from Dr. G. Dreyfuss (University of Pennsylvania), anti- analyzed by agarose gel electrophoresis. To quantify the mRNA
FXR1P antiserum was provided by Dr. A. Hoogeveen (Erasmus Uni- levels with the LightCycler (Roche Molecular Biochemicals), aliquots
versity, Rotterdam, Netherlands), and anti-FLAG M2 was from of first-stranded cDNA were amplified, and real-time fluorimetric
Sigma-Aldrich. intensity of SYBR green I was monitored. The ratio of different sam-
ples was calculated by LightCycler Data Analysis Software (Roche
Molecular Biochemicals) (see supplemental data).Mouse Brain Lysate Immunoprecipitation and Analysis
Whole brains from adult wt and Fmr1 congenic C57Bl/6J littermates
RNA Slot Blottingwere harvested and homogenized in 2 ml/brain ice-cold buffer (10
Total RNA (0.5 g) from normal or fragile X whole cell lysates andmM Hepes [pH 7.4], 200 mM NaCl, 30 mM EDTA, and 0.5% Triton
the same proportion of RNA from each fraction were used for RNAX-100) with 2 complete protease inhibitors (Boehringer-Mann-
blotting with gene-specific cDNA probes (see supplemental data).heim) and 400 U/ml rRNAsin (Promega) (Ishizuka et al., 1999). All
further manipulations of the brain lysates were performed at 4
C.
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